期刊文献+

急诊PCI联合替罗非班治疗ST段抬高心肌梗死的临床观察 被引量:3

Observe Effect of Emergent PCI Combined with Tirofiban Treatment on Patients with ST-segment Elevation Myocardial Infarction
下载PDF
导出
摘要 目的观察急诊PCI联合替罗非班治疗ST段抬高心肌梗死患者的疗效。方法选择本院2010年1月至2012年11月收治的56例心肌梗死患者,随机分为治疗组29例和对照组27例。治疗组经PCI术开通梗死相关动脉(IRA)后冠状动脉内注入盐酸替罗非班,而后持续泵入至术后24~48h。对照组应用常规PCI,对两组患者的PCI术后血流效果进行比较。结果治疗组急诊PCI术后TIMI血流3级的发生率(96.5%)较对照组(85.2%)显著增加(P<0.05)。结论替罗非班可改善STEMI患者梗塞相关血管PCI术后的TIMI血流。 Objective To observe effect of emergent PCI combined with tirofiban treatment on patients with ST-segment elevation myocardial infarction. Method Select 56 eases patients with myocardial infarction in our hospital from January 2008 to November 2010, Randomly divided into treatment group 29 cases and control group 27 cases, Treatment group inject tirofiban into the coronary artery after opening of infarct-related artery Via emergent PCI, Then continuous pumping tirofiban postoperative24,-48h, Control group receive application of emergent PCI only, Compare effect of blood flow of two groups of patients after PCI. Results The incidence of TIMI blood flow Level 3 of treatment group (96.5%) increase significantly than control group (85.2%) (P〈0.05) after emergent PCI. Conclusion Tirofiban can improved TIMI blood flow, of patients with ST-segment elevation myocardial infarction after PCI of infarct-related artery.
出处 《中国医药指南》 2013年第11期12-13,共2页 Guide of China Medicine
关键词 急性心肌梗死 介入治疗 替罗非班 冠状动脉 无复流 Acute myocardial infarction Interventional therapy Tirofiban Coronary artery No-reflow phenomenon
  • 相关文献

参考文献8

二级参考文献17

  • 1包宗明,史晓俊,张恒,蔡鑫,高大胜,王洪巨,吴士礼.冠状动脉介入治疗老年人非ST段抬高急性冠状动脉综合征疗效评价[J].中华老年医学杂志,2005,24(7):532-533. 被引量:2
  • 2杨新春,徐立,王乐丰,葛永贵,王红石,丁枭伟,王文君,邹阳春,李惟铭,刘宇.国产替罗非班对急性心肌梗死患者急诊介入治疗术后冠状动脉血流和心肌灌注影响的研究[J].中国循环杂志,2006,21(1):4-7. 被引量:91
  • 3宋玉娥,王琳,李芳,龚培力,王朝晖,党瑜华.盐酸替罗非班对急性冠状动脉综合征的疗效和安全性评价[J].临床心血管病杂志,2006,22(4):220-222. 被引量:71
  • 4Pasceri V,Patti G,Di Sciaacio G.Prevention of myocardial damage during coronary intervention[J].Cardiovasc Hematol Disord Drug Targets,2006,6(2):77-83.
  • 5Morishima I,Stone T,Okumura K,et al.Angiogrephic no-reflow phenomenon as apredicter of adverse long-term outcome in patinents treated with percutaneous transluminal coronary angioplasty for first acutemyocardial infarction[J].J Am Coll Cardio,2000,36(4):12022-12029.
  • 6Gibson CM,Cannon CP,Muphy SA,et a1.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J].Circulation,2000,101(2):125-130.
  • 7Shade MS,Tak WK.No-reflow phenomenon following percata-neout coronary intervention:an uncommon complicatin[J].Angi-ology,2000,51(3):247-252.
  • 8Antman EM,Anbe DT,Armstrong PW,et al.Aee/Att a guidelines for the management of patients SF elevation myocardial infarction-executive summary.A report of the amorican college of cardiology/american heart association task force on practice guidelines(Writing committee to revise the1999guidelines for the management of patients with a cute myocardial infaretion)[J].J Am Coll Cardiol,2004,44(3):671-719.
  • 9MOVAHED M R,BuTMAN s M.The pathogenesisand treatment of no-flow occurring during percutaneous coronary intervention[J].Cardiovasc RevaseMed,2008,9:56-61.
  • 10Celik T,Iyisoy A,Kursaklioglu H,et a1.The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction[J].Coron Artery Dis,2005,169(3):293-299.

共引文献24

同被引文献29

  • 1中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2012简本)[J].中华危重症医学杂志,2012,5(3):18-26.
  • 2Yang J, Kandzari DE, Gao Z, et al. Transradial versus transfemoralmethod of percutaneous coronary revasculariza- tion fofuuprotected left main coronary artery diseae:comppa- rison of procedural and late - term outcomes [ J ], JA ( X : Car- diovasc Inter,2010,3 : 1035 - 1042.
  • 3Cantor WJ. Fitchett D. Borgundvaag B, et al. Routine early angioplasty after fibrindysis for acute myocardial infarction TRANSFER - AMI Trial Investigators [ J ]. N Engl J Med, 2009,360:2705 - 2718.
  • 4Chamnarnphol N;Wisaratapong T Correlation between per- cutaneous coronary intervention volume, door - to - balloon time and mortality of patients with acute ST - segment ele- vation myocardial infarction [ J ]. J Mcd Assoc Thai, 2012, 95(3) :325.
  • 5Terkelsen C J, Sorensen JT. System delay and mortality a- mong patients with STEMI treated with primary percutancous coronary entervention[ J]. J AMA,2010,304(7):763.
  • 6Hiele H, Wohrle J, Neuhaus P, et al. Intracoronary com- pared with intravenous bolus abciximab application during primary percutaneous coronary intervention:design and ra- tionale of the Abciximab Intraeoronary Venus Intravenously Drug Application in ST- Elevation Myocardial Infarction (AIDA STEMI) trial [ J]. Am Heart J, 2010,159:547 - 554,.
  • 7Heestermans AA, Van Werkum JW, Harem C, Dill T, Gos- selink AT, De Boer M J, Van Houwelingen G, Hoorntje IC, Koopmans PC, Ten Berg JM, Van t Hof AW. Marked reduc- tion of early stent thrombosis with pre - hospital initiation of high - dose Tirofiban in ST - segment e|evation myocar- dial infarction[J]. J Thromb Haemost. 2009,7(10) : 1612 - 1628.
  • 8孙磊、黄春艳.冠心病介入治疗新进展研究[J].医药前沿,2013(1):18.
  • 9高海,段小春,李南.替罗非班对急性心肌梗死行直接冠状动脉介入治疗患者血浆B型脑钠肽及心功能的影响[J].中国全科医学,2012,15(6):618-621. 被引量:20
  • 10郭秋花.曲美他嗪与氢氯吡格雷联合给药对急性心肌梗死患者的影响[J].中国社区医师(医学专业),2012,14(19):29-30. 被引量:2

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部